Table 4.
Access to Health Care Among 587 Patients With Hypertension from 36 FQHC Clinics in Louisiana and Mississippi
| Characteristic | Taken Less or No Antihypertensive Medications, N (%) | Access to Care during COVID‐19 Pandemic | Telehealth Experiences (N=261) | Willing to Return to Primary Care Clinic, N (%) | ||||
|---|---|---|---|---|---|---|---|---|
| Able to Get Needed Medical Care, N (%) | Able to Get Prescription Medications, N (%) | Attended in‐Person Clinic Visits, N (%) | Received Telehealth Visits, N (%) | Received Needed Treatment, N (%) | Same or Better Care Quality Compared to In‐Person Visits, N (%) | |||
| Overall | 25 (4.3) | 160 (94.7) | 572 (97.6) | 193 (32.9) | 261 (44.5) | 252 (96.6) | 210 (80.8) | 522 (88.9) |
| Sex | ||||||||
| Female | 19 (5.4) | 100 (93.5) | 339 (97.1) | 118 (33.7) | 149 (42.7) | 143 (96.0) | 120 (81.1) | 308 (88.0) |
| Male | 6 (2.5) | 59 (96.7) | 232 (98.3) | 75 (31.8) | 111 (47.0) | 108 (97.3) | 89 (80.2) | 213 (90.3) |
| Race | ||||||||
| Black | 15 (3.9) | 100 (95.2) | 370 (97.4) | 130 (34.1) | 166 (43.7) | 161 (97.0) | 134 (81.2) | 335 (87.9) |
| Non‐Black | 10 (4.9) | 60 (93.7) | 202 (98.1) | 63 (30.6) | 95 (46.1) | 91 (95.8) | 76 (80.0) | 187 (90.8) |
| Age | ||||||||
| ≥65 y | 2 (1.3)* | 39 (95.1) | 154 (99.4) | 52 (33.5) | 59 (38.3) | 57 (96.6) | 45 (77.6) | 130 (83.9)* |
| <65 y | 23 (5.3)* | 121 (94.5) | 418 (97.0) | 141 (32.6) | 202 (46.8) | 195 (96.5) | 165 (81.7) | 392 (90.7)* |
| High school education or higher | ||||||||
| Yes | 19 (4.2) | 122 (93.1) | 442 (97.8) | 146 (32.3) | 203 (45.0) | 197 (97.0) | 164 (81.2) | 403 (89.2) |
| No | 6 (4.5) | 38 (100.0) | 129 (97.0) | 47 (35.1) | 58 (43.3) | 55 (94.8) | 46 (79.3) | 118 (88.1) |
| Type of insurance | ||||||||
| Public | 21 (5.0) | 117 (95.1) | 410 (97.4) | 144 (34.1) | 194 (46.1) | 187 (96.4) | 152 (78.8) | 366 (86.7)* |
| Private | 1 (1.3) | 24 (92.3) | 77 (98.7) | 25 (32.1) | 30 (38.5) | 29 (96.7) | 26 (86.7) | 74 (94.9)* |
| Uninsured | 3 (3.5) | 19 (95.0) | 84 (97.7) | 24 (27.9) | 37 (43.0) | 36 (97.3) | 32 (86.5) | 81 (94.2)* |
| Employment | ||||||||
| Employed | 12 (5.6) | 58 (92.1) | 211 (97.7) | 68 (31.5) | 99 (45.8) | 94 (94.9) | 80 (80.8) | 198 (91.7) |
| Retired | 9 (4.3) | 54 (96.4) | 206 (97.6) | 64 (30.3) | 87 (41.4) | 84 (96.6) | 69 (80.2) | 179 (84.8) |
| Unemployed | 4 (2.7) | 43 (95.6) | 145 (98.0) | 56 (37.8) | 69 (46.6) | 68 (98.6) | 56 (81.2) | 134 (90.5) |
| Body mass index | ||||||||
| Normal | 2 (3.4) | 12 (92.3) | 54 (93.1) | 17 (29.3) | 27 (46.6) | 24 (88.9) † | 25 (92.6) | 51 (87.9) |
| Overweight | 2 (1.5) | 37 (90.2) | 129 (98.5) | 42 (32.1) | 54 (41.2) | 50 (92.6) † | 42 (77.8) | 110 (84.0) |
| Obese | 20 (5.2) | 105 (96.3) | 376 (97.9) | 132 (34.3) | 176 (45.8) | 174 (98.9) † | 141 (80.1) | 350 (90.9) |
| Number of comorbidities § | ||||||||
| 0 | 7 (5.1) | 26 (86.7)* | 131 (96.3) | 42 (30.9) | 59 (43.4) | 54 (91.5) † | 47 (79.7) | 126 (92.6) |
| 1 | 11 (5.2) | 60 (93.7)* | 204 (96.7) | 60 (28.4) | 93 (44.3) | 89 (95.7) † | 78 (83.9) | 191 (90.5) |
| 2+ | 7 (3.1) | 71 (98.6)* | 226 (99.1) | 88 (38.4) | 99 (43.2) | 99 (100.0) † | 77 (78.6) | 197 (86.0) |
COVID‐19, coronavirus disease 2019; and FQHC, federally qualified health center.
*
P<0.05,
†
P<0.01,
‡
P<0.0001.
§
Comorbidities include diabetes mellitus, high cholesterol, history of stroke, myocardial infarction, heart failure, and chronic kidney disease in addition to hypertension.